CBCatherine Buettner

Catherine Buettner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Catherine Buettner has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Candyce H. Kroenke

    Brigham and Women’s Hospital, and Harvard Medical School

    1 shared publication
  • David M. Eisenberg

    Harvard Medical School

    1 shared publication
  • Gloria Y Yeh

    Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School

    1 shared publication
  • Michelle D. Holmes

    Brigham and Women’s Hospital, and Harvard Medical School

    1 shared publication
  • Murray A. Mittleman

    Affiliations Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medicine, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

    1 shared publication
  • Roger B. Davis

    Beth Israel Deaconess Medical Center and Harvard Medical School

    1 shared publication

Latest Publications

  • Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study

    by Catherine Buettner, Candyce H. Kroenke, Russell S. Phillips, Roger B. Davis, David M. Eisenberg, Michelle D. Holmes

    Among breast cancer survivors, we identified the prevalence and correlates of use of different types of complementary and alternative medicine (CAM). We included 2,022 women diagnosed with breast cancer 1998–2003 who responded to a survey about CAM use. We performed logistic regression to determine demographic and disease factors associated with use of different CAM therapies (including relaxation/imagery, spiritual healing, yoga, energy healing, acupuncture, massage, chiropractic, high-dose vitamins, herbs, and homeopathy). We also measured quality of life (QoL) using the SF36 and optimism using LOT-R and fit linear regression models to compare mean scores among CAM users and nonusers. Sixty-two percent of respondents used CAM. Younger age was the most consistent correlate of CAM use, but factors associated with CAM use varied by type of CAM. Chemotherapy was associated with use of relaxation/imagery (OR 1.3 95%CI 1.1–1.7). Radiotherapy was associated with use of high-dose vitamins (OR 1.5 95% CI 1.2–2.0). Tamoxifen or anastrozole treatment was associated with use of homeopathy (OR 0.5 95%CI 0.3–0.9). Users of most types of CAM had worse QoL scores than nonusers, but better QoL was found among users of yoga. The lowest QoL scores were associated with the use of energy healing. Optimism was higher among users of relaxation/imagery. Factors associated with CAM use varied according to type of CAM. Our finding of worse QoL among women using energy healing and better QoL among women using yoga suggests the need for longitudinal studies to determine the temporal relationships between these therapies and QoL.


  • Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors

    by Catherine Buettner, Gloria Y Yeh, Russell S Phillips, Murray A Mittleman, Ted J Kaptchuk

    Objective: To examine the evidence for the efficacy of ginseng (Panax spp.) on cardiovascular risk factors, including blood pressure, lipid profiles, and blood glucose, and to summarize reported cardiovascular adverse events. Data Sources: We searched MEDLINE, AMED, BIOSIS, CAB, EMBASE, and the Cochrane Controlled Trials databases through July 2005 and performed hand searches of bibliographies. Study Selection and Data Extraction: Short- or long-term, randomized, controlled trials and nonrandomized studies published in English were included. Data were extracted in a standardized manner, and 2 independent investigators assessed methodologic quality of the studies. Thirty-four studies were identified with results for blood pressure, lipids, and/or blood glucose. Due to heterogeneity of the studies, we were unable to perform a meta-analysis. Data on cardiovascular adverse events were extracted from events reported in identified studies and from case reports. Data Synthesis: The majority of studies were short term. Ginseng may slightly decrease blood pressure compared with placebo (range 0–4%). We found mixed results for an effect on lipids, with 5 of 9 studies showing improvement in one or more lipid parameters compared with baseline (range 7–44%). We identified several studies showing that ginseng lowers blood glucose, but overall studies were inconsistent. Conclusions: Current evidence does not support the use of ginseng to treat cardiovascular risk factors. Some studies suggest a small reduction in blood pressure. Despite some evidence showing that ginseng lowers blood glucose and improves lipid profiles, well-designed, randomized, controlled trials evaluating its effects are lacking.